Andere talen Royalty Pharma plc

Aandelen

RPRX

GB00BMVP7Y09

Geschatte realtime Cboe BZX Andere beurzen 19:29:48 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
27,72 ^USD	-1,89%		-6,54%	-1,12%

09/04	ROYALTY PHARMA PLC : Morgan Stanley herhaalt koopadvies	ZM
05/03	Transcript : Royalty Pharma plc Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Royalty Pharma : EEO-1 2023 Consolidated Report	03/04
Royalty Pharma : TD Cowen Health Care Conference Transcript	07/03
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	28/02
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	28/02
Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.	15/02
Royalty Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Royalty Pharma Swings to Q4 Net Income, Revenue Increases	15/02
Royalty Pharma: Q4 Earnings Snapshot	15/02
Royalty Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Earnings Flash (RPRX) ROYALTY PHARMA Reports Q4 Revenue $596M, vs. Street Est of $674.5M	15/02
Royalty Pharma Reports Q4 and Full Year 2023 Results	15/02
Royalty Pharma Reports Q4 and Full Year 2023 Results	15/02
Novartis will Morphosys schlucken - Zugriff auf Hoffnungsträger	06/02
Novartis data42 AG entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG for ?2.7 billion.	05/02
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024	30/01
Royalty Pharma Raises Quarterly Dividend by 5% to $0.21 per Class A Share, Payable March 15 to Shareholders of Record on Feb. 16	19/01
Royalty Pharma Announces Dividend Increase	19/01
Royalty Pharma plc Declares Dividend for the First Quarter of 2024, Payable on March 15, 2024	19/01
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference	08/01
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference	08/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Royalty Pharma plc

Aandelen

RPRX

GB00BMVP7Y09

Andere talen

Filters